Added by | pmartino |
---|---|
Group name | EquipePM |
Item Type | Journal Article |
Title | Fc-engineered monoclonal antibodies to reduce off-target liver uptake |
Creator | Mangeat et al. |
Author | Tristan Mangeat |
Author | Matthieu Gracia |
Author | Alexandre Pichard |
Author | Sophie Poty |
Author | Pierre Martineau |
Author | Bruno Robert |
Author | Emmanuel Deshayes |
Abstract | BACKGROUND: Radiolabeled-antibodies usually display non-specific liver accumulation that may impair image analysis and antibody biodistribution. Here, we investigated whether Fc silencing influenced antibody biodistribution. We compared recombinant 89Zr-labeled antibodies (human IgG1 against different targets) with wild-type Fc and with mutated Fc (LALAPG triple mutation to prevent binding to Fc gamma receptors; Fc?R). After antibody injection in mice harboring xenografts of different tumor cell lines or of immortalized human myoblasts, we analyzed antibody biodistribution by PET-CT and conventional biodistribution analysis. RESULTS: Accumulation in liver was strongly reduced and tumor-specific targeting was increased for the antibodies with mutated Fc compared with wild-type Fc. CONCLUSION: Antibodies with reduced binding to Fc?R display lower liver accumulation and better tumor-to-liver ratios. These findings need to be taken into account to improve antibody-based theragnostic approaches. |
Publication | EJNMMI research |
Volume | 13 |
Issue | 1 |
Pages | 81 |
Date | 2023-09-11 |
Journal Abbr | EJNMMI Res |
Language | eng |
DOI | 10.1186/s13550-023-01030-0 |
ISSN | 2191-219X |
Library Catalog | PubMed |
Extra | PMID: 37697076 PMCID: PMC10495296 |
Tags | bnif, Fc, Fc gamma receptor, first-last-corresponding, ipam, LALAPG mutation, ligue, mabimprove, Off-target, original, PET-CT, ram, siric, top |
Date Added | 2023/11/03 - 09:56:41 |
Date Modified | 2023/11/20 - 14:54:54 |
Notes and Attachments | Full Text (Attachment) PubMed entry (Attachment) |